COLORADO BLOOD CANCER INSTITUTE Trademark
Trademark Overview
On Tuesday, June 25, 2024, a trademark application was filed for COLORADO BLOOD CANCER INSTITUTE with the United States Patent and Trademark Office. The USPTO has given the COLORADO BLOOD CANCER INSTITUTE trademark a serial number of 98618154. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Thursday, December 26, 2024. This trademark is owned by CBCI Medical Group, PLLC. The COLORADO BLOOD CANCER INSTITUTE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Medical diagnosis and treatment of blood cancers and auto-immune diseases
General Information
Serial Number | 98618154 |
Word Mark | COLORADO BLOOD CANCER INSTITUTE |
Filing Date | Tuesday, June 25, 2024 |
Status | 638 - NEW APPLICATION - ASSIGNED TO EXAMINER |
Status Date | Thursday, December 26, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Medical diagnosis and treatment of blood cancers and auto-immune diseases |
Classification Information
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, June 25, 2024 |
Primary Code | 044 |
First Use Anywhere Date | Monday, May 24, 2010 |
First Use In Commerce Date | Monday, May 24, 2010 |
Trademark Owner History
Party Name | CBCI Medical Group, PLLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Englewood, CO 80112 |
Trademark Events
Event Date | Event Description |
Tuesday, June 25, 2024 | NEW APPLICATION ENTERED |
Tuesday, June 25, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, December 26, 2024 | ASSIGNED TO EXAMINER |